Pharma Journalist -

Accenture has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes. The platform, which…
Read More...

Alnylam Pharmaceuticals announced that the Company has initiated APOLLO-B, a global Phase 3 placebo-controlled clinical trial of patisiran, an intravenously administered RNAi…
Read More...

Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems,…
Read More...

H. Lundbeck A/S (Lundbeck) and Alder BioPharmaceuticals announced a definitive agreement for Lundbeck to acquire Alder. Under the terms of the agreement, Lundbeck will commence a tender…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to reduce the risk of…
Read More...

Oncoheroes Biosciences Inc and Boehringer Ingelheim International GmbH have signed a worldwide, exclusive licensing agreement for volasertib, an investigational anti-cancer compound…
Read More...

SMi Reports: SMi’s  9th annual Biobanking Conference will take place at the Copthorne Tara Hotel, London, on the 25th – 26th September 2019. There is only two weeks left until the…
Read More...

Akari Therapeutics, a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement (C5) and/or leukotriene…
Read More...

Eisai Co., Ltd. and Biogen Inc. announced the decision to discontinue the Phase III clinical studies (MISSION AD1, AD2) on the investigational oral BACE (beta amyloid cleaving enzyme)…
Read More...

Castle Creek Pharmaceutical Holdings, Inc. announced it has reached an agreement to acquire Fibrocell Science, a cell and gene therapy company focused on transformational autologous…
Read More...